Long-term follow-up after cure from chronic hepatitis C virus infection shows occult hepatitis and a risk of hepatocellular carcinoma in noncirrhotic patients.

Journal Information

Full Title: Eur J Gastroenterol Hepatol

Abbreviation: Eur J Gastroenterol Hepatol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest A.-S. D. has served as a speaker and/or consultant for AbbVie, BMS, Gilead, Janssen, Medivir, MSD and Roche. S.A. has served as a speaker and/or consultant for AbbVie, BMS, Gilead, Janssen, MSD/Merck, Medivir, Roche, and Tillotts Pharma, and has received research grants from AbbVie and Gilead. E.D.B. is currently an employee of Medivir AB (Stockholm, Sweden), although not at the time when the study was conducted. For the remaining authors, there are no conflicts of interest."

Evidence found in paper:

"This study was supported by the Research Committee of Region Örebro County Council (Grant numbers: OLL-522501 and OLL-590001). M.S. received research support from the Stockholm County Council, The Swedish Science Council and The Swedish Cancer Foundation."

Evidence found in paper:

"The study was approved by the Regional Ethical Review Board at Uppsala University, Sweden, approval registration number 2013/127 and 2013/127/1, and carried out according to the ethical guidelines of the Helsinki Declaration."

Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025